A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less-Reference-Cited by-同舟云学术

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

Published:1997-09-11 Issue:11 Volume:337 Page:725-733
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Hammer Scott M.,Squires Kathleen E.,Hughes Michael D.,Grimes Janet M.,Demeter Lisa M.,Currier Judith S.,Eron Joseph J.,Feinberg Judith E.,Balfour Henry H.,Deyton Lawrence R.,Chodakewitz Jeffrey A.,Fischl Margaret A.,Phair John P.,Pedneault Louise,Nguyen Bach-Yen,Cook Jon C.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM199709113371101

Cited by 2372 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis estimators for transportability with positivity violations by a continuous covariate;Journal of the Royal Statistical Society Series A: Statistics in Society;2024-09-02

2. The association between adherence to antiretroviral therapy and viral suppression under dolutegravir‐based regimens: an observational cohort study from Uganda;Journal of the International AIDS Society;2024-08

3. Semiparametric g-computation for survival outcomes with time-fixed exposures: An illustration;Annals of Epidemiology;2024-08

4. The epidemiology of HIV/AIDS and the use of antiretroviral therapy in Korea: a narrative review;The Ewha Medical Journal;2024-07-31

5. The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses;Science Translational Medicine;2024-05-22